TY - JOUR T1 - Combining longitudinal data from different cohorts to examine the life-course trajectory JF - medRxiv DO - 10.1101/2020.11.24.20237669 SP - 2020.11.24.20237669 AU - Rachael A. Hughes AU - Kate Tilling AU - Deborah A. Lawlor Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/26/2020.11.24.20237669.abstract N2 - Longitudinal data are necessary to reveal changes within the same individual as they age. However, rarely will a single cohort capture data throughout the lifespan. We describe in detail the steps needed to develop life-course trajectories from cohorts that cover different and overlapping periods of life. Such independent studies are likely from heterogenous populations which raises several challenges including: data harmonisation (deriving new harmonised variables from differently measured variables by identifying common elements across all studies); systematically missing data (variables not measured are missing for all participants of a cohort); and model selection with differing age ranges and measurement schedules. We illustrate how to overcome these challenges using an example which examines the effects of parental education, sex, and ethnicity on weight trajectories. Data were from five prospective cohorts (Belarus and four UK regions), spanning from birth to early adulthood during differing calendar periods. Key strengths of our approach include modelling trajectories over wide age ranges, sharing of information across studies and direct comparison of the same parts of the life-course in different geographical regions and time periods. We also introduce a novel approach of imputing individual-level covariates of a multilevel model with a nonlinear growth trajectory and interactions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by funding from the European Union Horizon 2020 research and innovation programme under grant agreement No 733206 (LifeCycle) and the European Research Council under the European Union Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement (Grant number 669545; DevelopObese). RAH, KT and DAL work in or are affiliated with a unit that is supported by the University of Bristol and UK Medical Research Council (MC_UU_00011/3 and MC_UU_00011/6). RAH is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant Number 215408/Z/19/Z) and DAL is a National Institute of Health Research Senior Investigator (NF-0616-10102). The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and RAH, KT AND DL will serve as guarantors for the contents of this paper. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). The BCG study was funded by the UK Department of Health. BiB is supported by the Wellcome Trust (WT101597MA) a joint grant from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC) (MR/N024397/1),the British Heart Foundation (CS/16/4/32482) and the National Institute for Health Research (NIHR) under its Collaboration for Applied Health Research and Care (CLAHRC) for Yorkshire and Humber and the Clinical Research Network (CRN). The CHS cohort was funded by Cancer Research UK and the MRC. PROBIT was originally funded by the National Health Research and Development Program (Health Canada), the Thrasher Research Fund, the United Nations Children Fund (UNICEF), and the European Regional Office of the World Health Organization (WHO). None of the funders influenced the content of the paper or the decision to publish. The views expressed in this paper are those of the authors and not necessarily any funder listed here.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Main caregivers (mostly mothers) have provided informed written consent and ethical approval for all aspects of data collection in BiB was granted by the Bradford National Health Service Research Ethics Committee (ref 06/Q1202/48). The institutional review board of the Montreal Children Hospital approved all aspects of data collection, and the participating parent/guardian signed informed consent forms in Russian at each phase.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are owned by the studies which prohibits me from sharing the data. However, researchers can access the data by submitting requests to the listed studies. ER -